Skip to main content
CNTA
NASDAQ Life Sciences

Previous Officer Files Intent to Sell $60.75M in Centessa Pharmaceuticals Stock

Analysis by Wiseek.ai
Sentiment info
Negative
Importance info
9
Price
$23.69
Mkt Cap
$3.362B
52W Low
$9.6
52W High
$30.58
Market data snapshot near publication time

summarizeSummary

A Form 144 filing indicates a previous officer's intent to sell approximately $60.75 million worth of Centessa Pharmaceuticals plc stock, primarily to cover stock option exercise and tax obligations.


check_boxKey Events

  • Proposed Stock Sale by Previous Officer

    Saurabh Saha, a previous officer of Centessa Pharmaceuticals plc, intends to sell 2,500,000 shares of Class A Common Stock.

  • Significant Transaction Value

    The proposed sale is valued at approximately $60.75 million.

  • Purpose of Sale

    Proceeds from the sale may be used to fund the exercise and hold of stock options, including related withholding taxes.


auto_awesomeAnalysis

Saurabh Saha, a previous officer of Centessa Pharmaceuticals plc, has filed a Form 144 indicating an intent to sell 2,500,000 shares, valued at approximately $60.75 million. This proposed sale represents a substantial reduction in holdings for a former executive. While the filing notes that proceeds may be used to fund the exercise and hold of stock options and related taxes, the significant dollar amount could still be perceived negatively by the market as it signals a large reduction in exposure by a former insider. Investors should monitor the actual sale of these shares.

At the time of this filing, CNTA was trading at $23.69 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $3.4B. The 52-week trading range was $9.60 to $30.58. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed CNTA - Latest Insights

CNTA
Apr 29, 2026, 8:00 AM EDT
Filing Type: DEF 14A
Importance Score:
7
CNTA
Mar 31, 2026, 4:38 PM EDT
Filing Type: DEFA14A
Importance Score:
10
CNTA
Mar 31, 2026, 4:31 PM EDT
Filing Type: 10-K
Importance Score:
10
CNTA
Mar 31, 2026, 8:18 AM EDT
Filing Type: DFAN14A
Importance Score:
10
CNTA
Mar 31, 2026, 6:45 AM EDT
Source: Dow Jones Newswires
Importance Score:
9
CNTA
Feb 13, 2026, 4:16 PM EST
Filing Type: 8-K
Importance Score:
7
CNTA
Jan 21, 2026, 4:58 PM EST
Filing Type: 144
Importance Score:
8
CNTA
Jan 06, 2026, 6:23 PM EST
Filing Type: 8-K/A
Importance Score:
7
CNTA
Jan 02, 2026, 4:45 PM EST
Filing Type: 144
Importance Score:
9